CVS Health Plans Two-Company Split and Raises Its Outlook
· 5 sources
CVS Health plans to separate into two publicly traded companies and raised its forecast, according to WSJ, MarketBeat and HME Business.
What happened
CVS Health (NYSE: CVS) announced plans to separate into two publicly traded companies, according to HME Business. The company made the announcement on Nov. 4, and MarketBeat reports it came alongside a higher outlook.
The Wall Street Journal reports that CVS raised its forecast, citing gains in health care benefits and pharmacy. HME Business says CVS described each of the two independent companies as committed to innovating to make healthcare more affordable and accessible.
The National Community Pharmacists Association said it is way too early to celebrate the plan, per HME Business. Bloomberg runs a piece arguing the spinoff is no magic bullet for growth, and MarketBeat also reports an insider purchase of 23,855 shares by an executive vice president.
Context
A corporate separation, or spinoff, divides a company's businesses into independent firms, each with its own public listing and management.
Why it matters
The split and the raised outlook bear on how investors and industry groups assess CVS Health's businesses, though the sources show differing views on its effect.
Stocks in this story
Price changes are shown for the trading day of the story and are a coincidence in time, not proof that the news caused them. Figures are ATLAS data from our database.
$193.73Fair range: $174.36 to $213.11The price ($83.85) is 56.7% below that figure.
Chance of a rise in 1 month
48%Probability of closing higher than today within 21 sessions.Normal range: half of the scenarios end between $76.41 and $91.10; 9 in 10, between $65.38 and $106.46.
Fair value, probabilities and earnings for every stock. Free account, no card. Information, not advice.
Information, not advice. This content is informational and is not an investment recommendation or an offer to buy or sell securities. ATLAS estimates come from statistical models using public data, can be wrong, and past performance does not guarantee future results. Disclaimer
ATLAS Signals
ATLAS Signals, every week
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy